Fundz

Strella Biotechnology, Inc. reported raising $3.32 Million in an initial SEC Form D filing, from an offering of $3.32 Million

PRIVATEApr 17, 2020

Amount Raised

$3.32 Million

$3.32 Million sold, per SEC Form D (first sale Apr 17, 2020)

Round Type

Seed

PhiladelphiaBiotechnology

Quick answer

Strella Biotechnology raised $3.32 Million in a Seed round, dated April 17, 2020. Strella Biotechnology is based in Philadelphia, Pennsylvania, United States.

How much did Strella Biotechnology raise?
Strella Biotechnology raised $3.32 Million in a Seed round on April 17, 2020.
What does Strella Biotechnology do?
Strella Biotechnology offers a biosensing platform that predicts the ripeness of fruit which reduces food waste and improves quality.
Where is Strella Biotechnology based and how big is it?
Strella Biotechnology is based in Philadelphia, Pennsylvania, United States. Fundz records about 11 employees.
Who are the decision-makers at Strella Biotechnology?
Fundz holds 2 contacts at Strella Biotechnology, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Strella Biotechnology that raised within 45 days of this round, from Fundz verified event records.

  • SQZ Biotechnologies Co raised $66M on June 1, 2020.
  • ALUNG TECHNOLOGIES INC raised $2M (Seed) on June 1, 2020.
  • Cardiff Oncology raised $2.5M (Seed) on June 1, 2020.
  • Luna Genetics raised $1.2M (Seed) on May 29, 2020.
  • Hilltop Biosciences raised $150K (Seed) on May 29, 2020.
  • Atea Pharmaceuticals, Inc. raised $107M on May 29, 2020.

Who to call at Strella Biotechnology, and when

A new round usually means Strella Biotechnology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Strella Biotechnology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Strella Biotechnology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Strella Biotechnology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Strella Biotechnology

Location

Philadelphia, Pennsylvania, United States

About

Strella Biotechnology offers a biosensing platform that predicts the ripeness of fruit which reduces food waste and improves quality.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Strella Biotechnology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJacob J., Executive Officer, Director, Promoter hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Strella Biotechnology's next move

See what Strategic adds

Strella Biotechnology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.